logging in or signing up Pharmacology aSGuest1150 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 1007 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: October 16, 2008 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Pharmacology : Pharmacology Introduction Key Topics : Key Topics How are drugs described and referenced? What are the relevant drug laws and regulations? What are the factors affecting how drugs are given? What are some of the key terms? Drug Descriptions : Drug Descriptions Names Sources Forms Reference Materials Components of Drug Profiles Drug Names : Drug Names Chemical Name: 2-(diethylamino)-2’,6’-acetooxylid monohydrochloride monohydrate. Not Particularly Useful! Drug Names : Drug Names Generic Name: lidocaine hydrochloride Official Name: Lidocaine Hydrochloride, USP Brand (Trade) Name: Xylocaine® Much More Useful Drug References : Drug References USP PDR Drug Inserts Nursing Drug References Pocket Field Guides Digital Guides Jeff’s Pharmacology Review http://www.templejc.edu/ems/drugs/PharmIndex.html Components of a Drug Profile : Components of a Drug Profile Names Classification (including prototype) Mechanism of Action Kinetics Indications Contraindications Side Effects Interactions Routes of Administration Dosage How Supplied Special Considerations Drug Laws : Drug Laws Pure Food and Drug Act of 1906 Harrison Narcotic Act of 1914 Federal Food, Drug and Cosmetic Act of 1938 Durham-Humphrey Amendments Comprehensive Drug Abuse Prevention and Control Act of 1970 Controlled Substances : Controlled Substances State and Local Laws : State and Local Laws ‘Scope of Practice’ Laws Responsibility vs Authority of Medical Direction Drug Standardization : Drug Standardization Assays Bioequivalence Bioassay USP is the official standard Research and Development : Research and Development Key points from FDA handout Purpose? What are controls? What are the phases? What is an IND? An NDA? Why is skepticism important? Handout Source: http://www.fda.gov/fdac/special/newdrug/testing.html Six Rights of Medication Administration : Six Rights of Medication Administration Right Medication Right Dose Right Time Right Route Right Patient Right Documentation Pregnancy Considerations : Pregnancy Considerations Increased maternal HR, CO and blood volume May affect absorption, distribution, effectiveness Drugs may cross placenta Drugs may cross into breast milk Tertatogens Pregnancy Categories : Pregnancy Categories A: controlled studies in pregnancy (<1 %). B: animal studies show no risk; Inadequate human data. C: animal studies show risk, inadequate human data. D: human data show risk, benefit may outweigh risk. X: animal or human data positive for risk. Use unwarranted. Pediatric Considerations : Pediatric Considerations Oral absorption Thinner skin ( topical absorption) Plasma protein concentration Free protein-bound drug availability Extracellular fluid in neonate Altered metabolic rates Elimination/metabolism BSA/weight based dosing important! Geriatric Considerations : Geriatric Considerations Oral absorption Plasma protein concentration Muscle mass, body fat Liver/renal function Multiple drugs Multiple diseases Some Terminology : Some Terminology Receptor affinity Efficacy 1° vs. 2nd messengers Up vs. down receptor regulation Agonist vs. antagonist -lytic vs. -mimetic Inhibition (antagonism) Competitive vs. noncompetitive vs. irreversible Allergic reaction Idiosyncrasy Tolerance More Terminology : More Terminology Cross tolerance Tachyphylaxis Cumulative effect Dependence Drug interactions Summation (1+1=2) Additive effect Synergism (1+1=3) Potentiation Interference Basics of Drug Classification : Basics of Drug Classification Knowledge grouping Prototype drug Predictive value Drug Classification : Drug Classification By chemistry electrolytes By mechanism Beta blockers benzodiazepines By disease antihypertensives Antiemetics Resources : Resources Clinical Pharmacology 2000 http://cp.gsm.com/default.asp University of Kansas Medical Center http://www.kumc.edu/AMA-MSS/study/pharmacology.htm Infomed Online! http://www.infomed.org/index-e.html Mosby’s GenRX http://www.genrx.com/genrxfree/Top_200_2000/Top_200_2000.html Resources : Resources Hardin MD (Meta-Directory) http://www.lib.uiowa.edu/hardin/md/pharm.html Top 200 Prescription Drugs http://www.rxlist.com/top200.htm Medline Plus: Consumer Information on Prescription Drugs http://www.nlm.nih.gov/medlineplus/druginformation.html FDA Online (Testing Drugs in People) http://www.fda.gov/fdac/special/newdrug/testing.html You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Pharmacology aSGuest1150 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 1007 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: October 16, 2008 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Pharmacology : Pharmacology Introduction Key Topics : Key Topics How are drugs described and referenced? What are the relevant drug laws and regulations? What are the factors affecting how drugs are given? What are some of the key terms? Drug Descriptions : Drug Descriptions Names Sources Forms Reference Materials Components of Drug Profiles Drug Names : Drug Names Chemical Name: 2-(diethylamino)-2’,6’-acetooxylid monohydrochloride monohydrate. Not Particularly Useful! Drug Names : Drug Names Generic Name: lidocaine hydrochloride Official Name: Lidocaine Hydrochloride, USP Brand (Trade) Name: Xylocaine® Much More Useful Drug References : Drug References USP PDR Drug Inserts Nursing Drug References Pocket Field Guides Digital Guides Jeff’s Pharmacology Review http://www.templejc.edu/ems/drugs/PharmIndex.html Components of a Drug Profile : Components of a Drug Profile Names Classification (including prototype) Mechanism of Action Kinetics Indications Contraindications Side Effects Interactions Routes of Administration Dosage How Supplied Special Considerations Drug Laws : Drug Laws Pure Food and Drug Act of 1906 Harrison Narcotic Act of 1914 Federal Food, Drug and Cosmetic Act of 1938 Durham-Humphrey Amendments Comprehensive Drug Abuse Prevention and Control Act of 1970 Controlled Substances : Controlled Substances State and Local Laws : State and Local Laws ‘Scope of Practice’ Laws Responsibility vs Authority of Medical Direction Drug Standardization : Drug Standardization Assays Bioequivalence Bioassay USP is the official standard Research and Development : Research and Development Key points from FDA handout Purpose? What are controls? What are the phases? What is an IND? An NDA? Why is skepticism important? Handout Source: http://www.fda.gov/fdac/special/newdrug/testing.html Six Rights of Medication Administration : Six Rights of Medication Administration Right Medication Right Dose Right Time Right Route Right Patient Right Documentation Pregnancy Considerations : Pregnancy Considerations Increased maternal HR, CO and blood volume May affect absorption, distribution, effectiveness Drugs may cross placenta Drugs may cross into breast milk Tertatogens Pregnancy Categories : Pregnancy Categories A: controlled studies in pregnancy (<1 %). B: animal studies show no risk; Inadequate human data. C: animal studies show risk, inadequate human data. D: human data show risk, benefit may outweigh risk. X: animal or human data positive for risk. Use unwarranted. Pediatric Considerations : Pediatric Considerations Oral absorption Thinner skin ( topical absorption) Plasma protein concentration Free protein-bound drug availability Extracellular fluid in neonate Altered metabolic rates Elimination/metabolism BSA/weight based dosing important! Geriatric Considerations : Geriatric Considerations Oral absorption Plasma protein concentration Muscle mass, body fat Liver/renal function Multiple drugs Multiple diseases Some Terminology : Some Terminology Receptor affinity Efficacy 1° vs. 2nd messengers Up vs. down receptor regulation Agonist vs. antagonist -lytic vs. -mimetic Inhibition (antagonism) Competitive vs. noncompetitive vs. irreversible Allergic reaction Idiosyncrasy Tolerance More Terminology : More Terminology Cross tolerance Tachyphylaxis Cumulative effect Dependence Drug interactions Summation (1+1=2) Additive effect Synergism (1+1=3) Potentiation Interference Basics of Drug Classification : Basics of Drug Classification Knowledge grouping Prototype drug Predictive value Drug Classification : Drug Classification By chemistry electrolytes By mechanism Beta blockers benzodiazepines By disease antihypertensives Antiemetics Resources : Resources Clinical Pharmacology 2000 http://cp.gsm.com/default.asp University of Kansas Medical Center http://www.kumc.edu/AMA-MSS/study/pharmacology.htm Infomed Online! http://www.infomed.org/index-e.html Mosby’s GenRX http://www.genrx.com/genrxfree/Top_200_2000/Top_200_2000.html Resources : Resources Hardin MD (Meta-Directory) http://www.lib.uiowa.edu/hardin/md/pharm.html Top 200 Prescription Drugs http://www.rxlist.com/top200.htm Medline Plus: Consumer Information on Prescription Drugs http://www.nlm.nih.gov/medlineplus/druginformation.html FDA Online (Testing Drugs in People) http://www.fda.gov/fdac/special/newdrug/testing.html